CompanyGraph
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- ScaleMarket cap is $1.79B, above the global median of $1.15B
- FinancialsAltman Z-Score 14.57: safe zone
- Interpretations3 currently firing — 3
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.21%Below 5Y avg (0.75%)
Annual Rate
INR 3.50Paid annual
Payout Ratio
11.0%Sustainable
Last Ex-Dividend
Sep 18, 2025
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
170.54BINR1.79B · vs all stocks (USD)
Trailing P/E
53.01xvs Medical Instruments & Supplies peers
Revenue (TTM)
18.75BINR196.96M · vs all stocks (USD)
Profit Margin
17.18%vs Medical Instruments & Supplies peers
Beta
0.0240xvs all stocks
52-Week Change
-19.51%vs all stocks
Market Capitalization
170.54BINR1.79B · vs all stocks (USD)
Enterprise Value
166.04BINR1.74B · vs all stocks (USD)
Trailing P/E
53.01xvs Medical Instruments & Supplies peers
Forward P/E
35.73xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
9.09xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
5.48xvs Medical Instruments & Supplies peers
Enterprise to Revenue
8.85xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
37.54xvs Medical Instruments & Supplies peers
Gross Margin
66.67%vs Medical Instruments & Supplies peers
Profit Margin
17.18%vs Medical Instruments & Supplies peers
Operating Margin
13.50%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
5.75%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
10.85%vs Medical Instruments & Supplies peers
Revenue (TTM)
18.75BINR196.96M · vs all stocks (USD)
Revenue per Share (TTM)
185.06INRUpdated Jul 20, 2026Quarterly Revenue Growth
21.30%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
12.78BINR134.28M · vs all stocks (USD)
EBITDA (TTM)
5.68BINR59.63M · vs all stocks (USD)
Net Income (TTM)
3.22BINR33.83M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-27.80%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
2.46BINR25.88M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-3.09BINR-32.49M · vs all stocks (USD)
Trailing Annual Dividend Rate
3.50INRUpdated Jul 20, 2026Trailing Annual Dividend Yield
0.21%vs all stocks
5-Year Average Dividend Yield
0.75%vs all stocks
Payout Ratio
11.02%vs Medical Instruments & Supplies peers
Minority Interest (Equity)
430.70MINRFY2026 · Mar 31, 2026Revenue
18.75BINRFY2026 · Mar 31, 2026Cost of Goods Sold
5.97BINRFY2026 · Mar 31, 2026Gross Profit
12.78BINRFY2026 · Mar 31, 2026Operating Income
3.27BINR34.32M · vs all stocks (USD)
Pre-tax Income
4.27BINRFY2026 · Mar 31, 2026Income Tax Expense
961.79MINRFY2026 · Mar 31, 2026Net Income
3.31BINRFY2026 · Mar 31, 2026EBIT
4.46BINRFY2026 · Mar 31, 2026EBITDA (Income Statement)
5.68BINRFY2026 · Mar 31, 2026Research & Development
298.76MINRFY2026 · Mar 31, 2026Other Operating Expenses
4.04BINRFY2026 · Mar 31, 2026Non-operating Interest Expense
182.91MINRFY2026 · Mar 31, 2026Preferred Stock Dividends
0.00INRFY2026 · Mar 31, 2026Operating Cash Flow
2.22BINRFY2026 · Mar 31, 2026Free Cash Flow
-834.37MINRFY2026 · Mar 31, 2026Cash & Cash Equivalents (End of Period)
512.28MINRFY2026 · Mar 31, 2026Starting Profit (CF Statement)
4.27BINRFY2026 · Mar 31, 2026Other Non-cash Items
-336.04MINRFY2026 · Mar 31, 2026Change in Accounts Receivable (CF)
-993.10MINRFY2026 · Mar 31, 2026Change in Other Assets/Liabilities
-721.85MINRFY2026 · Mar 31, 2026Capital Expenditures
-3.06BINRFY2026 · Mar 31, 2026Net Acquisitions
-3.86BINRFY2026 · Mar 31, 2026Other Investing Activity
-331.60MINRFY2026 · Mar 31, 2026Net Investing Cash Flow
-7.25BINRFY2026 · Mar 31, 2026Common Dividends Paid
-354.31MINRFY2026 · Mar 31, 2026Net Financing Cash Flow
-350.93MINRFY2026 · Mar 31, 2026Shares Outstanding
101.36MSharesUpdated Jul 20, 2026Float Shares
33.57MSharesUpdated Jul 20, 2026% Held by Insiders
65.08%vs all stocks
% Held by Institutions
17.36%vs all stocks
Total Cash (MRQ)
8.27BINR86.86M · vs all stocks (USD)
Total Cash per Share (MRQ)
81.59INRUpdated Jul 20, 2026Total Debt (MRQ)
3.54BINR37.14M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.1123xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
3.37xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
306.44INRUpdated Jul 20, 2026Total Assets
39.19BINR411.57M · vs all stocks (USD)
Total Current Assets
19.42BINRFY2026 · Mar 31, 2026Total Liabilities
7.69BINRFY2026 · Mar 31, 2026Total Non-current Assets
19.77BINRFY2026 · Mar 31, 2026Total Non-current Liabilities
1.94BINRFY2026 · Mar 31, 2026Total Current Liabilities
5.76BINRFY2026 · Mar 31, 2026Cash & Cash Equivalents
512.28MINRFY2026 · Mar 31, 2026Other Short-term Investments
8.21BINRFY2026 · Mar 31, 2026Accounts Receivable
5.31BINRFY2026 · Mar 31, 2026Inventory
4.34BINRFY2026 · Mar 31, 2026Accounts Payable
1.23BINRFY2026 · Mar 31, 2026Short-term Debt
2.96BINRFY2026 · Mar 31, 2026Other Current Liabilities
564.29MINRFY2026 · Mar 31, 2026Long-term Debt
572.49MINRFY2026 · Mar 31, 2026Other Non-current Liabilities
100.08MINRFY2026 · Mar 31, 2026Common Stock (Book)
506.80MINRFY2026 · Mar 31, 2026Total Shareholders' Equity
31.49BINR330.77M · vs all stocks (USD)
52-Week Low
1.18KINRUpdated Jul 20, 202652-Week High
2.14KINRUpdated Jul 20, 202652-Week Change
-19.51%vs all stocks
Beta
0.0240xvs all stocks
50-Day MA
1.55KINRUpdated Jul 20, 2026200-Day MA
1.61KINRUpdated Jul 20, 2026Avg 10-Day Volume
84.27KSharesUpdated Jul 20, 2026Avg 30-Day Volume
148.63KSharesUpdated Jul 20, 2026Diluted EPS (TTM)
31.70INRUpdated Jul 20, 20263 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Industry-Benchmarked ROA and Margin Elevated
Returns and margins have sat in the top of its industry across five years.
Reads
Revenue Growing With Receivables Growing
Revenue has risen three years, and what customers owe has risen with it.
Reads
Is this company growing?
Multi-Year Revenue, Profit, And Income Growth
Revenue has risen in each of three years, gross profit in each of four, and it has made a profit in all five.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 14.57: safe zoneNotable
Altman Z-Score: 14.57
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Market cap is $1.79B, above the global median of $1.15BNotable
Market cap (USD): 1,791,142,703.318Global Median: 1,146,734,693.424
Companies that share the same coordination system — how they create, deliver, or capture value.
Jiangsu Shuangxing Color Plastic New Materials Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Chongqing Three Gorges Water Conservancy and Electric Power Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Minda Corporation Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Shenzhen Success Electronics Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Shenzhen Edadoc Technology Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Jiaze Renewables Co Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Shenzhen Mason Technologies Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Ambiq Micro, Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Org Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Innovex International Inc.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Companies that share active interpretations — structural patterns currently present in both stocks.
Fiem Industries Ltd.
3 interpretationsRevenue Growing With Receivables GrowingMulti-Year Revenue, Profit, And Income GrowthIndustry-Benchmarked ROA and Margin Elevated
Harmony Biosciences Holdings, Inc.
3 interpretationsRevenue Growing With Receivables GrowingMulti-Year Revenue, Profit, And Income GrowthIndustry-Benchmarked ROA and Margin Elevated
Suzhou Sepax Technologies Inc.
3 interpretationsRevenue Growing With Receivables GrowingMulti-Year Revenue, Profit, And Income GrowthIndustry-Benchmarked ROA and Margin Elevated